In this review, we aim to summarize current evidence on serum adropin levels in systemic autoimmune rheumatic diseases (ARDs) and to examine the potential role of adropin in modulating the complex pathophysiological pathways involved in these disorders. The gene discussed is ENHO; the disease is acute respiratory distress syndrome.